Lynch-like syndrome: Characterization and comparison with EPCAM deletion carriers

International Journal of Cancer

Volumn 136, Issue 7, 2015, Pages 1568-1578

  Kang, So Young ^a,b   Park, Cheol Keun ^a   Chang, Dong Kyung ^a   Kim, Jong Won ^a   Son, Hee Jung ^a   Cho, Yong Beom ^a   Yun, Seong Hyeon ^a   Kim, Hee Cheol ^a   Kwon, Moosik ^b   Kim, Kyoung Mee ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Sungkyunkwan University   (South Korea)

Author keywords

Familial colon cancer; Lynch like syndrome; Mismatch repair deficiency; Polymerase

Indexed keywords

DNA DIRECTED DNA POLYMERASE DELTA; DNA DIRECTED DNA POLYMERASE EPSILON; EPITHELIAL CELL ADHESION MOLECULE; MICROSATELLITE DNA; MISMATCH REPAIR PROTEIN; PROTEIN MLH1; PROTEIN MSH2; CELL ADHESION MOLECULE; DNA DIRECTED DNA POLYMERASE GAMMA; EPCAM PROTEIN, HUMAN; TUMOR ANTIGEN;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DNA METHYLATION; EPCAM GENE; FEMALE; GENE DELETION; GENETIC VARIABILITY; GERMLINE MUTATION; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; MISMATCH REPAIR; PROMOTER REGION; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; SOMATIC MUTATION; YOUNG ADULT; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; GENETICS; HETEROZYGOTE; HOMOZYGOTE; MUTATION; NUCLEOTIDE SEQUENCE; ONSET AGE; VERY ELDERLY;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; CELL ADHESION MOLECULES; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA MISMATCH REPAIR; DNA MUTATIONAL ANALYSIS; DNA POLYMERASE III; FEMALE; GENE DELETION; GERM-LINE MUTATION; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; MUTATION; YOUNG ADULT;

EID: 84920876016     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29133     Document Type: Article

References (43)

1. Moreira L, Balaguer F, Lindor N, et al. Identification of Lynch syndrome among patients with colorectal cancer. JAMA 2012;308:1555-65.
2. Lynch HT, Lynch PM, Lanspa SJ, et al. Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications. Clin Genet 2009;76:1-18.
3. Rustgi AK. The genetics of hereditary colon cancer. Genes Dev 2007;21:2525-38.
4. Boland CR, Goel A. Microsatellite instability in colorectal cancer. Gastroenterology 2010;138:2073-87.e3.
5. Percesepe A, Anti M, Marra G, et al. Role of clinical criteria in the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC): results of a multivariate analysis. Int J Cancer 1994;58:799-802.
6. Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004;96:261-8.
7. Ligtenberg MJ, Kuiper RP, Chan TL, et al. Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1. Nat Genet 2009;41:112-17.
8. Rumilla K, Schowalter KV, Lindor NM, et al. Frequency of deletions of EPCAM (TACSTD1) in MSH2-associated Lynch syndrome cases. J Mol Diagn 2011;13:93-9.
9. Kloor M, Voigt AY, Schackert HK, et al. Analysis of EPCAM protein expression in diagnostics of Lynch syndrome. J Clin Oncol 2011;29:223-7.
10. Rodriguez-Soler M, Perez-Carbonell L, Guarinos C, et al. Risk of cancer in cases of suspected lynch syndrome without germline mutation. Gastroenterology 2013;144:926-32.e1; quiz e13-4.
11. Mensenkamp AR, Vogelaar IP, van Zelst-Stams WA, et al. Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatch-repair deficiency in Lynch syndrome-like tumors. Gastroenterology 2014;146:643-6.e8.
12. Sourrouille I, Coulet F, Lefevre JH, et al. Somatic mosaicism and double somatic hits can lead to MSI colorectal tumors. Fam Cancer 2013;12:27-33.
13. Carethers JM. Differentiating lynch-like from lynch syndrome. Gastroenterology 2014;146:602-4.
14. Nardon E, Glavac D, Benhattar J, et al. A multicenter study to validate the reproducibility of MSI testing with a panel of 5 quasimonomorphic mononucleotide repeats. Diagn Mol Pathol 2010;19:236-42.
15. Park HY, Kang SY, Kang GH, et al. EBV infection and mismatch repair deficiency mediated by loss of hMLH1 expression contribute independently to the development of multiple synchronous gastric carcinomas. J Surg Oncol 2012;106:777-82.
16. Palles C, Cazier JB, Howarth KM, et al. Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas. Nat Genet 2013;45:136-44.
17. The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012;487:330-7.
18. Briggs S, Tomlinson I. Germline and somatic polymerase epsilon and delta mutations define a new class of hypermutated colorectal and endometrial cancers. J Pathol 2013;230:148-53.
19. Park SJ, Rashid A, Lee JH, et al. Frequent CpG island methylation in serrated adenomas of the colorectum. Am J Pathol 2003;162:815-22.
20. Huth C, Kloor M, Voigt AY, et al. The molecular basis of EPCAM expression loss in Lynch syndrome-associated tumors. Mod Pathol 2012;25:911-16.
21. van Dijk MC, Rombout PD, Boots-Sprenger SH, et al. Multiplex ligation-dependent probe amplification for the detection of chromosomal gains and losses in formalin-fixed tissue. Diagn Mol Pathol 2005;14:9-16.
22. Zhang J, Lindroos A, Ollila S, et al. Gene conversion is a frequent mechanism of inactivation of the wild-type allele in cancers from MLH1/MSH2 deletion carriers. Cancer Res 2006;66:659-64.
23. Musulen E, Blanco I, Carrato C, et al. Usefulness of epithelial cell adhesion molecule expression in the algorithmic approach to Lynch syndrome identification. Hum Pathol 2013;44:412-16.
24. Kohonen-Corish MR, Macrae F, Genuardi M, et al. Deciphering the colon cancer genes - report of the InSiGHT-Human Variome Project Workshop, UNESCO, Paris 2010. Hum Mutat 2011;32:491-4.
25. Adzhubei IA, Schmidt S, Peshkin L, et al. A method and server for predicting damaging missense mutations. Nat Methods 2010;7:248-9.
26. Pritchard CC, Smith C, Salipante SJ, et al. Colo-Seq provides comprehensive lynch and polyposis syndrome mutational analysis using massively parallel sequencing. J Mol Diagn 2012;14:357-66.
27. Lee SE, Kang SY, Cho J, et al. Pyloric gland adenoma in Lynch syndrome. Am J Surg Pathol 2014;38:784-92.
28. Mangold E, Pagenstecher C, Friedl W, et al. Spectrum and frequencies of mutations in MSH2 and MLH1 identified in 1,721 German families suspected of hereditary nonpolyposis colorectal cancer. Int J Cancer 2005;116:692-702.
29. Woods MO, Younghusband HB, Parfrey PS, et al. The genetic basis of colorectal cancer in a population-based incident cohort with a high rate of familial disease. Gut 2010;59:1369-77.
30. Desai DC, Lockman JC, Chadwick RB, et al. Recurrent germline mutation in MSH2 arises frequently de novo. J Med Genet 2000;37:646-52.
31. Kuiper RP, Vissers LE, Venkatachalam R, et al. Recurrence and variability of germline EPCAM deletions in Lynch syndrome. Hum Mutat 2011;32:407-14.
32. Kovacs ME, Papp J, Szentirmay Z, et al. Deletions removing the last exon of TACSTD1 constitute a distinct class of mutations predisposing to Lynch syndrome. Hum Mutat 2009;30:197-203.
33. Niessen RC, Hofstra RM, Westers H, et al. Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome. Genes Chromosomes Cancer 2009;48:737-44.
34. Nagasaka T, Rhees J, Kloor M, et al. Somatic hypermethylation of MSH2 is a frequent event in Lynch Syndrome colorectal cancers. Cancer Res 2010;70:3098-108.
35. Kim TM, Laird PW, Park PJ. The landscape of microsatellite instability in colorectal and endometrial cancer genomes. Cell 2013;155:858-68.
36. Arnold S, Buchanan DD, Barker M, et al. Classifying MLH1 and MSH2 variants using bioinformatic prediction, splicing assays, segregation, and tumor characteristics. Hum Mutat 2009;30:757-70.
37. Ma X, Zhang B, Zheng W. Genetic variants associated with colorectal cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence. Gut 2014;63:326-36.
38. Lee SC, Guo JY, Lim R, et al. Clinical and molecular characteristics of hereditary non-polyposis colorectal cancer families in Southeast Asia. Clin Genet 2005;68:137-45.
39. Wang Y, Friedl W, Lamberti C, et al. A novel missense mutation in the DNA mismatch repair gene hMLH1 present among East Asians but not among Europeans. Hum Hered 1998;48:87-91.
40. Yap HL, Chieng WS, Lim JR, et al. Recurring MLH1 deleterious mutations in unrelated Chinese Lynch syndrome families in Singapore. Fam Cancer 2009;8:85-94.
41. Kim YM, Choe CG, Cho SK, et al. Three novel germline mutations in MLH1 and MSH2 in families with Lynch syndrome living on Jeju island, Korea. BMB Rep 2010;43:693-7.
42. Ohsawa T, Sahara T, Muramatsu S, et al. Colorectal cancer susceptibility associated with the hMLH1 V384D variant. Mol Med Rep 2009;2:887-91.
43. Chan TL, Yuen ST, Kong CK, et al. Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer. Nat Genet 2006;38:1178-83.